Doctor profile · Federal record
Dr. SUJATHA YELLINEDI, M.D.
Hematology & Oncology Physician (CMS: MEDICAL ONCOLOGY) · PETERSBURG, VA
- NPI 1265406607
- Accepts Medicare
- MIPS 74.6 / 100 · 2023
- 32 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
200 MEDICAL PARK BLVD, SUITE 200
PETERSBURG, VA 238059274
(804) 431-1100
fax (804) 862-1094 - Additional location
-
263 Medical Park Blvd
Petersburg, VA 23805 - Additional location
-
4730 Puddledock Rd Ste 100
Prince George, VA 238751274
(804) 452-3850
fax (804) 541-7585 - Mailing address
-
7202 GLEN FOREST DR, SUITE 200
RICHMOND, VA 232263781
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- February 21, 2024
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Virginia #0101237658
- Medicaid (2)
- VA #010148707 · VA #010148723
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265406607. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
62,847
Distinct HCPCS
10
Medicare allowed
$580,823
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 34,680 | 53 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 12,600 | 15 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 4,400 | 13 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 4,320 | 26 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,450 | 45 | $0 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 883 | 256 | $125 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 800 | 15 | $7 | |
J0640 |
Injection, leucovorin calcium, per 50 mg | 621 | 14 | $4 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 470 | 19 | $1 | |
J9190 |
Injection, fluorouracil, 500 mg | 452 | 16 | $2 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 1,954. This provider delivers 32× the peer median.Open Payments
Industry payments received
All-time total
$1,708
Transactions
56
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $219.89 | |
| Merck Sharp & Dohme LLC | 7 | $166.07 | |
| PFIZER INC. | 5 | $111.72 | |
| Legend Biotech USA Inc. | 4 | $87.88 | |
| Janssen Biotech, Inc. | 4 | $86.97 | |
| Ipsen Biopharmaceuticals, Inc | 3 | $76.18 | |
| Eisai Inc. | 3 | $74.57 | |
| Gilead Sciences, Inc. | 3 | $62.45 | |
| AstraZeneca Pharmaceuticals LP | 3 | $61.30 | |
| BeiGene USA, Inc. | 3 | $60.36 | |
| Celgene Corporation | 3 | $55.89 | |
| Alexion Pharmaceuticals, Inc. | 2 | $51.33 | |
| EMD Serono, Inc. | 2 | $45.16 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $44.11 | |
| SERVIER PHARMACEUTICALS LLC | 2 | $37.66 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
628
Patients
80
Total drug cost
$905,487
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Xarelto (Rivaroxaban) | Brand | 92 | 12 | $63,295 |
| Eliquis (Apixaban) | Brand | 75 | 15 | $57,788 |
| Anastrozole | Generic | 71 | 20 | $2,575 |
| Letrozole | Generic | 48 | 0 | $2,465 |
| Dexamethasone | Generic | 45 | 17 | $1,195 |
| Tamoxifen Citrate | Generic | 41 | 0 | $1,221 |
| Warfarin Sodium | Generic | 38 | 0 | $564 |
| Gabapentin | Generic | 35 | 0 | $202 |
| Hydroxyurea | Generic | 34 | 0 | $700 |
| Prednisone | Generic | 33 | 0 | $279 |